When you look at a comparison between PRICERA™ and NR (Nicotinamide Riboside) and NMN (Nicotinamide Mononucleotide) –
Pricera comes out the clear winner!
|PRICERA™ clinically proven to outperform both NR* and NMN**|
|Simultaneously increases ATP, NAD+, and GSH||✔||✖||✖|
|Utilizes the dominant pathway for NAD+ synthesis||✔||✖||✖|
|Utilizes shunt pathway for NAD+ synthesis||✖||✔||✔|
|Stable in most applications||✔||✖||✖|
|Orally bioavailable (high amounts end up in blood)||✔||✖||✖|
|Survives digestive process intact||✔||✖||✖|
|*NR – Nicotinamide Riboside **NMN – Nicotinamide Mononucleotide|
- Avery B (Department of Pharmaceutics and Drug Delivery, The University of Mississippi), 2017. Pharmacokinetic Analysis of Plasma Nicotinamide and 1-Methyl Nicotinamide Concentrations in Toxicokinetic Study of NIAGEN (Nicotinamide Riboside).Study Report No AV151003. Unpublished Study Report, 9 pp.
- Liu L. et al. Quantitative analysis of NAD synthesis-breakdown fluxes. CellMetab.27, 1067–1080 (2018).
- Xue, YQ, Increasing NAD level by D-ribose and its combinations. PCT/US2019/031889 patent pending.